The impact of supplemental macular carotenoids in Alzheimer’s disease: A randomized Clinical Trial. (CARDS Study 2).
Introduction This trial represents a major milestone in our research, being the first randomized controlled trial to investigate whether supplementation with all three macular carotenoids lutein, zeaxanthin, and meso-zeaxanthin could…
